Published in Medical Letter on the CDC and FDA, December 13th, 2009
"As part of this effort, Goodsaid et al. have carried out work, described in this issue, on the formal qualification of novel biomarkers of acute renal toxicity in animals," wrote D.C. Throckmorton and colleagues, Food & Drug Administration.
The researchers concluded: "The authors' experiences highlight the importance of collaboration and the role of regulators."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA